Home/Hedge Fund Intelligence/Travere Therapeutics, Inc.
Nasdaq: TVTXStockForm 13F30 Jun 2026

Hedge funds that hold Travere Therapeutics, Inc. Nasdaq: TVTX

CUSIP 89422G107 · who reports it, how much, and how much it matters to them

36 of the 720 hedge fund managers we track reported shares of Travere Therapeutics, Inc. (Nasdaq: TVTX) on Form 13F for 30 June 2026. Between them they reported USD 1.3bn. The largest position belongs to Perceptive Advisors, at USD 213m. The manager with the most riding on it is Kynam Capital Management, where it is 6.3% of the reported book.

Managers reporting it36of 720 we track
Value they reportUSD 1.3bnshares only, 30 Jun 2026
Funds they run377with a file on PPLI.com
Largest positionUSD 213mPerceptive Advisors
Typical weight0.1%median share of a manager's book
Heaviest weight6.3%Kynam Capital Management

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

36 managers, USD 1.3bn between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Travere Therapeutics, Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Perceptive Advisors6 funds on PPLI.comUSD 213m3.2%
2Adage Capital Management1 fund on PPLI.comUSD 146m0.2%
3Rock Springs Capital Management2 funds on PPLI.comUSD 124m6.0%
4Kynam Capital Management1 fund on PPLI.comUSD 114m6.3%
5Renaissance Technologies13 funds on PPLI.comUSD 104m0.1%
6Armistice Capital1 fund on PPLI.comUSD 89m1.1%
7Two Sigma Investments35 funds on PPLI.comUSD 89m0.1%
8D. E. Shaw & Co.15 funds on PPLI.comUSD 82m0.0%
9Marshall Wace LLP84 funds on PPLI.comUSD 76m0.1%
10Eversept Partners3 funds on PPLI.comUSD 45m2.4%
11POINT72 Asset Management17 funds on PPLI.comUSD 27m0.0%
12Graham Capital Management18 funds on PPLI.comUSD 25m0.5%
13Artia Global Partners1 fund on PPLI.comUSD 19m3.6%
14Capricorn Fund Managers8 funds on PPLI.comUSD 18m1.4%
15Orbimed Advisors1 fund on PPLI.comUSD 14m0.3%
16Palo Alto Investors6 funds on PPLI.comUSD 9.5m1.3%
17Aquatic Capital Management3 funds on PPLI.comUSD 9m0.3%
18Voleon Capital Management13 funds on PPLI.comUSD 8.3m0.2%
19Apis Capital Advisors4 funds on PPLI.comUSD 6.4m0.6%
20Squarepoint Ops7 funds on PPLI.comUSD 6.2m0.0%
21Exoduspoint Capital Management7 funds on PPLI.comUSD 5.5m0.0%
22HighVista Strategies27 funds on PPLI.comUSD 4.9m1.1%
23Millennium Management6 funds on PPLI.comUSD 4.8m0.0%
24Jain Global1 fund on PPLI.comUSD 2.9m0.0%
25Engineers Gate Manager1 fund on PPLI.comUSD 2.7m0.0%
26Walleye Capital8 funds on PPLI.comUSD 2.2m0.0%
27Citadel Advisors32 funds on PPLI.comUSD 2.2m0.0%
28Balyasny Asset Management25 funds on PPLI.comUSD 2m0.0%
29JW Asset Management5 funds on PPLI.comUSD 1.7m0.5%
30Fora Capital1 fund on PPLI.comUSD 1.6m0.1%
31Verition Fund Management3 funds on PPLI.comUSD 1.4m0.0%
32The Quarry1 fund on PPLI.comUSD 571,0000.0%
33Tudor Investment Corporation10 funds on PPLI.comUSD 338,0000.0%
34Freestone Grove Partners1 fund on PPLI.comUSD 244,0000.0%
35Graticule Asia Macro Advisors8 funds on PPLI.comUSD 195,0000.0%
36Elequin Capital2 funds on PPLI.comUSD 9090.0%
Next: where it matters most
Where it matters most

For Kynam Capital Management it is 6.3% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Kynam Capital ManagementUSD 114m6.3%
2Rock Springs Capital ManagementUSD 124m6.0%
3Artia Global PartnersUSD 19m3.6%
4Perceptive AdvisorsUSD 213m3.2%
5Eversept PartnersUSD 45m2.4%
6Capricorn Fund ManagersUSD 18m1.4%
7Palo Alto InvestorsUSD 9.5m1.3%
8HighVista StrategiesUSD 4.9m1.1%
9Armistice CapitalUSD 89m1.1%
10Apis Capital AdvisorsUSD 6.4m0.6%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Travere Therapeutics, Inc.

What is the ticker symbol of Travere Therapeutics, Inc.?

Travere Therapeutics, Inc. trades under the symbol TVTX on the Nasdaq. Its CUSIP, the code used on Form 13F, is 89422G107.

Which hedge funds own Travere Therapeutics, Inc. (Nasdaq: TVTX)?

36 of the 720 hedge fund managers PPLI.com tracks reported Travere Therapeutics, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Perceptive Advisors (USD 213m), Adage Capital Management (USD 146m), Rock Springs Capital Management (USD 124m), Kynam Capital Management (USD 114m) and Renaissance Technologies (USD 104m).

How many hedge funds hold Travere Therapeutics, Inc.?

36 managers in our coverage reported it, and between them they run 377 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Travere Therapeutics, Inc.?

Kynam Capital Management, where the position was 6.3% of the reported 13F book at 30 June 2026.

Does this show who is short Travere Therapeutics, Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Travere Therapeutics, Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.